EESM:XETRA BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation

EUR 270.15 0.30 0.111173
Icon

BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (EESM:XETRA) Stock Analysis and Price Targets

ETF | Others | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 270.15

+0.30 (+0.11)%

EUR 0.22B

40.00

EUR -1.00

N/A

Icon

EESM:XETRA

BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (EUR)
ETF | XETRA
EUR 270.15
0.00 0
Take a Tour

BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (EESM:XETRA) Stock Forecast

N/A

Based on the BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation stock forecast from 0 analysts, the average analyst target price for BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation is not available over the next 12 months. BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation’s stock price was EUR 270.15. BNP Paribas Easy MSCI Europe Small Caps SRI S-Series PAB 5% Capped UCITS ETF Capitalisation’s stock price has changed by +1.62% over the past week, -0.22% over the past month and +3.39% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...